Midcap Value Alert: 3 Years of Subscription at the Price of 1
Here is the latest financial fact sheet of BRAWN BIOTECH. For more details, see the BRAWN BIOTECH quarterly results and BRAWN BIOTECH share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 5.0 |
No. of shares | m | 3.00 |
1 Week | % | 21.9 |
1 Month | % | 30.8 |
1 Year | % | 69.0 |
52 week H/L | Rs | 27.4/14.4 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
BRAWN BIOTECH EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 60 | 46 | 32 | 44 | 23 | |
Low | Rs | 33 | 17 | 18 | 17 | 14 | |
Sales per share (Unadj.) | Rs | 217.3 | 165.4 | 116.6 | 28.7 | 74.1 | |
Earnings per share (Unadj.) | Rs | 4.4 | 2.0 | -1.8 | -5.5 | -2.9 | |
Diluted earnings per share | Rs | 4.4 | 2.0 | -1.8 | -5.5 | -2.9 | |
Cash flow per share (Unadj.) | Rs | 4.6 | 2.1 | -1.7 | -5.3 | -2.5 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 28.9 | 30.9 | 29.3 | 24.1 | 21.0 | |
Adj. book value per share | Rs | 28.9 | 30.9 | 29.3 | 24.1 | 21.0 | |
Shares outstanding (eoy) | m | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | |
Price / Sales ratio | x | 0.2 | 0.2 | 0.2 | 1.1 | 0.2 | |
Avg P/E ratio | x | 10.5 | 16.0 | -13.6 | -5.5 | -6.3 | |
P/CF ratio (eoy) | x | 10.3 | 15.1 | -14.4 | -5.7 | -7.2 | |
Price / Book Value ratio | x | 1.6 | 1.0 | 0.8 | 1.3 | 0.9 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 140 | 95 | 75 | 91 | 55 | |
Total wages/salary | Rs m | 30 | 31 | 24 | 18 | 14 |
BRAWN BIOTECH INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 652 | 496 | 350 | 86 | 222 | |
Other income | Rs m | 7 | 2 | 3 | 0 | 0 | |
Total revenues | Rs m | 659 | 498 | 353 | 86 | 222 | |
Gross profit | Rs m | 12 | 7 | -6 | -20 | -3 | |
Depreciation | Rs m | 0 | 0 | 0 | 1 | 1 | |
Interest | Rs m | 1 | 1 | 0 | 1 | 0 | |
Profit before tax | Rs m | 18 | 8 | -4 | -21 | -4 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 5 | 2 | 2 | -5 | 5 | |
Profit after tax | Rs m | 13 | 6 | -6 | -16 | -9 | |
Gross profit margin | % | 1.8 | 1.5 | -1.7 | -23.3 | -1.4 | |
Effective tax rate | % | 26.2 | 27.9 | -53.0 | 22.4 | -110.8 | |
Net profit margin | % | 2.0 | 1.2 | -1.6 | -19.1 | -3.9 |
BRAWN BIOTECH BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 217 | 192 | 127 | 122 | 134 | |
Current liabilities | Rs m | 137 | 108 | 49 | 63 | 80 | |
Net working cap to sales | % | 12.3 | 16.9 | 22.4 | 68.0 | 24.1 | |
Current ratio | x | 1.6 | 1.8 | 2.6 | 1.9 | 1.7 | |
Inventory Days | Days | 3 | 6 | 9 | 25 | 10 | |
Debtors Days | Days | 92,163 | 110,315 | 96,824 | 118,974 | 87,270 | |
Net fixed assets | Rs m | 7 | 10 | 10 | 10 | 10 | |
Share capital | Rs m | 30 | 30 | 30 | 30 | 30 | |
"Free" reserves | Rs m | 57 | 63 | 58 | 42 | 33 | |
Net worth | Rs m | 87 | 93 | 88 | 72 | 63 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 225 | 202 | 137 | 132 | 144 | |
Interest coverage | x | 26.8 | 16.5 | -8.5 | -32.6 | -44.7 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 2.9 | 2.5 | 2.5 | 0.7 | 1.5 | |
Return on assets | % | 6.2 | 3.2 | -3.7 | -12.0 | -6.0 | |
Return on equity | % | 15.4 | 6.4 | -6.3 | -22.8 | -13.8 | |
Return on capital | % | 21.7 | 9.4 | -3.7 | -28.5 | -6.4 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 1.7 | 4.7 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 9 | 16 | 0 | 0 | |
Fx inflow | Rs m | 613 | 449 | 319 | 0 | 0 | |
Fx outflow | Rs m | 0 | 9 | 16 | 0 | 0 | |
Net fx | Rs m | 613 | 441 | 303 | 0 | 0 |
BRAWN BIOTECH CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 2 | -1 | 0 | 2 | 3 | |
From Investments | Rs m | -0 | -0 | 0 | -3 | -1 | |
From Financial Activity | Rs m | -1 | -0 | -0 | -1 | -0 | |
Net Cashflow | Rs m | 1 | -1 | -0 | -2 | 2 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Brij Raj Gupta | COMP SEC: Priyanka Sharma | YEAR OF INC: 1985 | BSE CODE: 530207 | FV (Rs): 10 | DIV YIELD (%): - |
More Trading Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare BRAWN BIOTECH With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian share markets made a cautious start on Monday in a week where inflation figures could make or break hopes for earlier US rate cuts.